The present invention provides methods and compositions for treating a cancer, and/or an autoimmune disease, by modulating the expression and/or activity of IGSF8 and its binding ligands. The pharmaceutical compositions may include, but are not limited to, antibodies that specifically bind human IGSF8, and have an activity of inhibiting IGSF8-mediated immunosuppression in a subject in need thereof.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
A61K 39/00 - Medicinal preparations containing antigens or antibodies
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 35/04 - Antineoplastic agents specific for metastasis
G01N 33/50 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing
G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
2.
COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8
Methods and compositions are provided. The methods and compositions are used for treating a cancer, and/or an autoimmune disease, by modulating the expression and/or activity of IGSF8 and its binding ligands. The pharmaceutical compositions may include, but are not limited to, antibodies that specifically bind human IGSF8, and have an activity of inhibiting IGSF8-mediated immunosuppression in a subject in need thereof.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
The present invention provides methods and compositions for treating a cancer, and/or an autoimmune disepase, by modulating the expression and/or activity of IGSF8 and its binding ligands. The pharmaceutical compositions may include, but are not limited to, antibodies that specifically bind human IGSF8, and have an activity of inhibiting IGSF8-mediated immunosuppression in a subject in need thereof.
C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
Goods & Services
Pharmaceutical preparations for the treatment of cancer;
pharmaceutical preparations for the treatment of genetic
diseases. Conducting early evaluations in the field of new
pharmaceuticals; research and development of pharmaceutical
and biopharmaceutical preparations and medicines;
pharmaceutical and biotechnology products development;
research and development in the pharmaceutical and
biotechnology fields; pharmaceutical and biopharmaceutical
research services in the fields of cancer and genetic
diseases; pharmaceutical and biopharmaceutical research
services in the nature of biomarker identification;
pharmaceutical and biopharmaceutical research services,
namely, artificial intelligence assisted drug discovery and
development services; software as a service services (saas)
featuring artificial intelligence software for drug
discovery and development.
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
Goods & Services
(1) Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases. (1) Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; pharmaceutical and biotechnology products development; research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service services (saas) featuring artificial intelligence software for drug discovery and development.
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
Goods & Services
Pharmaceutical preparations for the treatment of cancer;
pharmaceutical preparations for the treatment of genetic
diseases. Conducting early evaluations in the field of new
pharmaceuticals; research and development of pharmaceutical
and biopharmaceutical preparations and medicines;
pharmaceutical and biotechnology products development;
research and development in the pharmaceutical and
biotechnology fields; pharmaceutical and biopharmaceutical
research services in the fields of cancer and genetic
diseases; pharmaceutical and biopharmaceutical research
services in the nature of biomarker identification;
pharmaceutical and biopharmaceutical research services,
namely, artificial intelligence assisted drug discovery and
development services; software as a service services for
artificial intelligence software for drug discovery and
development.
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
Goods & Services
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service services (SAAS) featuring artificial intelligence software for drug discovery and development
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
Goods & Services
(1) Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases. (1) Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; pharmaceutical and biotechnology products development; research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service services for artificial intelligence software for drug discovery and development.
9.
COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8
The present invention provides methods and compositions for treating a cancer, and/or an autoimmune disease, by modulating the expression and/or activity of IGSF8 and its binding ligands. The pharmaceutical compositions may include, but are not limited to, antibodies that specifically bind human IGSF8, and have an activity of inhibiting IGSF8-mediated immunosuppression in a subject in need thereof.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
42 - Scientific, technological and industrial services, research and design
Goods & Services
Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development; platform as a service services (PAAS) featuring computer software platforms for drug development and discovery
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services;software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development
42 - Scientific, technological and industrial services, research and design
Goods & Services
Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services;software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
Goods & Services
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services;software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development
14.
COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8
Methods and compositions are provided. The methods and compositions are used for treating a cancer, and/or an autoimmune disease, by modulating the expression and / or activity of IGSF8 and its binding ligands. The pharmaceutical compositions may include, but are not limited to, antibodies that specifically bind human IGSF8, and have an activity of inhibiting IGSF8-mediated immunosuppression in a subject in need thereof.
A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
15.
COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8
Methods and compositions are provided. The methods and compositions are used for treating a cancer, and/or an autoimmune disease, by modulating the expression and / or activity of IGSF8 and its binding ligands. The pharmaceutical compositions may include, but are not limited to, antibodies that specifically bind human IGSF8, and have an activity of inhibiting IGSF8-mediated immunosuppression in a subject in need thereof.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
